Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-22-012273

Dake Benjamin T sold 40,000 shares at an average $17.67 ($706,772)

  • Dake Benjamin T acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Dake Benjamin T

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-06 Exercise or conversion : show line 1 in the form +2,412 $1.74 $4,197 2,412 D
2022-12-06 Exercise or conversion : show line 2 in the form +37,588 $2.14 $80,438 40,000 D
2022-12-06 Sale : show line 3 in the form −2,011 $15.61 $31,386 37,989 D
2022-12-06 Sale : show line 4 in the form −1,259 $16.90 $21,275 36,730 D
2022-12-06 Sale : show line 5 in the form −36,115 $17.80 $642,861 615 D
2022-12-06 Sale : show line 6 in the form −615 $18.29 $11,250 0 D
Open-market sales · 40,000 sh · avg $17.67 · $706,772

Table II: Derivative

4 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-12-06 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −905 $1.74 2030-09-03 906 11,772 D
2022-12-06 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −1,507 $1.74 2030-09-03 1,507 30,136 D
2022-12-06 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −1,018 $2.14 2031-04-01 1,018 28,515 D
2022-12-06 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −36,570 $2.14 2031-04-01 36,570 218,030 D
Loading xslF345X03/form4-12082022_061206.xml…